Therini Bio

Sacramento, CA · Founded 2016 · Privately Held (backing)

Developer of biotechnology drugs designed to offer a potential treatment to protect the nervous system from multiple sclerosis damage. Therini Bio is based in Sacramento, CA and was founded in 2016. It was valued at $100 million at its later-stage round in May 2025, the last priced event on record. It has raised $102 million across 2 recorded rounds; the latest was a $74.9 million later-stage round in Mar 2023.

PMV mark · valuation
$100.0M
Oct 2026
Priced at
its later-stage round
May 2025
Total raised
$101.5M
Last round
Later Stage VC
Mar 2023
What is Therini Bio worth?
$100.0MPrivateMarketView mark · Oct 2026

Valued at $100.0M at its later-stage round, May 2025. Nothing has traded since.

Free account
More of Therini Bio with a free account
  • ·The complete investor list: 15 names
  • ·Watch Therini Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Therini Bio funding history

2 rounds
DateRoundRaisedPost-money
Mar 2023Later Stage VC$74.9M▮
May 2019Early Stage VC$9.4M▮
Unlock post-money valuations

Membership and data by Private Market View

Therini Bio valuation

Therini Bio was valued at $100 million at its later-stage round in May 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Therini Bio raised?

Therini Bio has raised $102 million across 2 recorded rounds since 2019. The largest was a $9.4 million early-stage round in May 2019; the most recent was a $74.9 million later-stage round in Mar 2023.

Therini Bio has filed 3 Form Ds with the SEC since 2020, most recently in Sep 2025 ($74.9 million sold to 17 investors).

How Therini Bio's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Therini Bio, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Therini Bio

What is Therini Bio worth?
Therini Bio is valued at $100.0M as of Oct 2026. Valued at $100.0M at its later-stage round, May 2025. Nothing has traded since.
How much has Therini Bio raised?
Therini Bio has raised $101.5M in total funding across 2 recorded rounds.
When did Therini Bio last raise?
Therini Bio last raised in Mar 2023 (Later Stage VC), raising $74.9M.